Opko Health (OPK) Current Deferred Revenue (2014 - 2024)
Opko Health's (OPK) quarterly Current Deferred Revenue came in at $6000.0 in Q4 2024, down 14.29% YoY from $7000.0 in Q1 2024, and down 14.29% on a QoQ basis from $7000.0 in Q4 2023.
Opko Health (OPK) Current Deferred Revenue (2014 - 2024) Analysis & Trends
Opko Health (OPK) has 4 years of Current Deferred Revenue data on file, last reported at $6000.0 in Q4 2024.
- Quarterly Current Deferred Revenue fell 14.29% year-over-year to $6000.0 in Q4 2024, while the trailing twelve-month figure through Dec 2024 was $6000.0 (down 14.29% YoY) and the FY2024 annual result came in at $6000.0, down 14.29% from the prior year.
- Current Deferred Revenue eased to $6000.0 in Q4 2024, from $7000.0 in the prior quarter.
- In the past five years, Current Deferred Revenue ranged from a high of $7000.0 in Q4 2023 to a low of $6000.0 in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 234.15 Bn | 230.09 Bn | 8.34 Bn |
| 2 | Danaher | 152.10 Bn | 147.75 Bn | 3.61 Bn |
| 3 | Natera | 48.48 Bn | 47.38 Bn | 486.15 Mn |
| 4 | Agilent Technologies | 44.35 Bn | 42.55 Bn | 990.00 Mn |
| 5 | Iqvia Holdings | 43.68 Bn | 41.60 Bn | 1.44 Bn |
| 6 | Idexx Laboratories | 43.02 Bn | 42.83 Bn | 779.09 Mn |
| 7 | Illumina | 34.39 Bn | 33.22 Bn | 770.00 Mn |
| 8 | Mettler Toledo International | 28.29 Bn | 28.24 Bn | 650.22 Mn |
| 9 | Labcorp Holdings | 27.51 Bn | 27.37 Bn | 1.11 Bn |
| 10 | Opko Health | 1.13 Bn | 824.59 Mn | 80.02 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 6,000.00 |
| Dec 31, 2023 | 7,000.00 |
| Sep 30, 2015 | 254.10 Mn |
| Dec 31, 2014 | 6.70 Mn |